Viviane Monges - 21 May 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Reporting relationship: Director
Issuer ticker: PHVS
Reported as of: 21 May 2026
Net transaction value: -$292,853
SEC form: 4
Accepted by SEC: 26 May 2026, 17:53:25 UTC
Prior SEC filing: 18 Mar 2026
Next SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Marnus Nel, Attorney-in-Fact for Viviane Monges

Key filing fact

Viviane Monges filed Form 4 for Pharvaris N.V. (PHVS) on 26 May 2026.

Key facts

This page summarizes Viviane Monges's Form 4 filing for Pharvaris N.V. (PHVS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 May 2026, 17:53.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$292,853.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001838204 Primary reporting owner

Monges Viviane

Relationship: Director
Address: 1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature: /s/ Marnus Nel, Attorney-in-Fact for Viviane Monges
Signature date: 26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Sale

Transaction value: $292,853
Shares: -9,667
Change %: -64%
Price: $30.29
Shares after: 5,500
Date: 21 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated by 513 shares due to administrative errors in the number of shares reported as withheld for tax obligations in connection with RSU releases occurring on April 11, 2025 and March 12, 2026. This filing reflects the corrected beneficial ownership amount.

Footnote F2

The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.08 to $30.49 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.